| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
11,496,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Q BioMed is a biotechnology acceleration and development company focused on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. Co. has a portfolio of therapeutic products, including radiopharmaceuticals for metastatic cancer bone pain (Strontium-89 and Metastron™) and various development stage products: QBM-001 for rare pediatric non-verbal autism spectrum disorder, Uttroside-B for liver cancer, and MAN 01 for glaucoma. Co.'s MAN platform has several potential therapeutics in development in various indications, including vascular and infectious diseases. The infectious diseases Co. treats include influenza, Coronavirus, Ebola and others.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rosenstadt William S |
Chief Legal Officer |
• • • |
2022-05-26 |
4 |
A |
$25,000.00 |
$2,147,483,647 |
D/D |
250,000 |
926,910 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2022-05-26 |
4 |
A |
$20,000.00 |
$2,147,483,647 |
D/D |
200,000 |
2,641,800 |
|
- |
|
| Rosenstadt William S |
Chief Legal Officer |
• • • |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
653,761 |
|
- |
|
| Rosenstadt William S |
Chief Legal Officer |
• • • |
2019-10-16 |
4 |
A |
$0.00 |
$0 |
D/D |
115,761 |
618,761 |
|
- |
|
| Panicucci Rick |
Director |
– • – |
2019-10-09 |
4 |
A |
$0.00 |
$0 |
D/D |
500 |
15,500 |
|
- |
|
| Panicucci Rick |
Director |
– • – |
2019-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
15,000 |
|
- |
|
| Panicucci Rick |
Director |
– • – |
2019-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
500 |
13,000 |
|
- |
|
| Panicucci Rick |
Director |
– • – |
2019-04-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
12,500 |
|
- |
|
| Panicucci Rick |
Director |
– • – |
2019-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
11,000 |
|
- |
|
| Panicucci Rick |
Director |
– • – |
2018-11-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
10,000 |
|
- |
|
| Panicucci Rick |
Director |
– • – |
2018-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
7,500 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-07-12 |
4 |
S |
$2.11 |
$13,530 |
D/D |
(6,400) |
2,435,400 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-07-10 |
4 |
AS |
$2.85 |
$19,934 |
D/D |
(7,000) |
2,441,800 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-07-09 |
4 |
AS |
$3.37 |
$23,578 |
D/D |
(7,000) |
2,448,800 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-07-06 |
4 |
AS |
$3.58 |
$24,690 |
D/D |
(6,900) |
2,455,800 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-07-05 |
4 |
AS |
$3.54 |
$23,342 |
D/D |
(6,600) |
2,462,700 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-07-03 |
4 |
AS |
$3.46 |
$7,610 |
D/D |
(2,200) |
2,469,300 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-07-02 |
4 |
AS |
$3.42 |
$6,836 |
D/D |
(2,000) |
2,471,500 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-06-29 |
4 |
AS |
$3.40 |
$7,138 |
D/D |
(2,100) |
2,473,500 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-06-28 |
4 |
AS |
$3.39 |
$17,961 |
D/D |
(5,300) |
2,475,600 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-06-27 |
4 |
AS |
$3.44 |
$16,833 |
D/D |
(4,900) |
2,480,900 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-06-26 |
4 |
AS |
$3.43 |
$13,033 |
D/D |
(3,800) |
2,485,800 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-06-25 |
4 |
AS |
$3.42 |
$4,785 |
D/D |
(1,400) |
2,489,600 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-06-21 |
4 |
S |
$3.45 |
$11,388 |
D/D |
(3,300) |
2,491,000 |
|
- |
|
| Corin Denis |
Chief Executive Officer |
• • • |
2018-06-21 |
4 |
AS |
$3.47 |
$19,765 |
D/D |
(5,700) |
2,494,300 |
|
- |
|
70 Records found
|
|
Page 1 of 3 |
|
|
